Hemab Therapeutics (Nasdaq: COAG), a clinical-stage biotechnology company developing therapies that reimagine the treatment ...
OCT-980 is designed to stabilize misfolded rhodopsin and restore proper cellular trafficking. By directly targeting the ...
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it will report its third quarter 2026 financial and ...
COPENHAGEN, Denmark; September 24, 2026 – Genmab A/S (Nasdaq: GMAB) announced today that the Board of Directors decided to ...
J.P. Morgan, Morgan Stanley, TD Cowen and UBS Investment Bank are acting as lead book-running managers for the offering.
Elephas Biosciences Corporation, developer of a functional precision medicine platform for oncology therapy response ...
Alamar Biosciences, Inc. (Nasdaq: ALMR), a leader in precision proteomics dedicated to enabling the earliest detection of ...
Compact system offers research laboratories a time-saving and cost-efficient way to automate work still done by hand ...
The 2026 honorees include innovative companies whose treatments have significantly improved rare disease patient outcomes, ...
Dr. Gwathmey comes to NYU Langone from the University of Virginia Health System where, as an orthopedic surgeon in 2013, he ...
Metastasis—the spread of cancer from a primary tumor to other parts of the body—causes most cancer-related deaths. But how ...
Led by Relevance Ventures, the funding will support the completion of Aqua Medical's ongoing U.S. RESTORE-1 pilot study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results